Research has suggested that environmental factors have a greater impact on the risk of alcoholic liver disease (ALD) than genetic predisposition.

Stem cells found in amniotic fluid can be transformed into a more versatile state similar to embryonic stem cells, according to a study published in the journal Molecular Therapy.

Scientists at the University of East Anglia have discovered a ‘constant cloud’ of potent inflammatory molecules surrounding the cells responsible for diseases such as thickening of the arteries and rheumatoid arthritis.

Evotec AG has announced that it has licensed to Janssen Pharmaceuticals, Inc. a portfolio of small molecules and biologics designed to trigger the regeneration of insulin-producing beta cells.

The team from the Nottingham Respiratory Research Unit at The University of Nottingham are keen to recruit both asthmatics and healthy adults on to the clinical trial, which is part of a European-wide study into the condition.

Scientists at the University of Reading have made a significant breakthrough in cornea transplant research that could make future procedures more successful.

A third of the world’s human population is infected with a dormant tuberculosis bacteria, primarily people living in developing countries. The bacteria presents a lifelong TB risk.

A female scientist from the Queen's University Ionic Liquid Laboratories (QUILL) Research Centre has won a prestigious fellowship for her work on ionic liquids enabling biomedical applications.

The Institute for Material Synthesis and Manufacturing Processes develops and researches high-performance materials and innovative manufacturing processes for efficient energy converters of the future. The range of topics includes solid oxide fuel cells (SOFC), thermal barrier coatings for high-efficiency gas turbines, gas separation membranes for lower emissions in power plants, and next generation lithium-ion batteries.

Genevac, world leaders in solvent removal technology, has over 20 year's experience of designing and supplying robust evaporators that can withstand the rigors of working in a chemical laboratory environment.

AMSBIO, a supplier of advanced 3D tools to the life science community, recently participated in a '3D Cell Culture in Drug Discovery and Disease Modeling' webinar. Due to huge demand, the webinar which aired on 22nd May, has been reproduced in an on-demand version.

The development of novel medical imaging techniques to revolutionise cancer detection and treatment will be the result of a new partnership announced between Queen’s University Belfast and Cirdan Imaging Ltd.

A new drug combination could offer hope to children with neuroblastoma – one of the deadliest forms of childhood cancer – by boosting the effectiveness of a promising new gene-targeted treatment.

SEURAT-1 is the first phase of a longer term research initiative aiming at Safety Evaluation Ultimately Replacing Animal Testing.

Thermo Fisher Scientific Inc. has launched the Thermo Scientific Pharma 11, a new version of its parallel co-rating twin-screw extruder designed specifically for pharmaceutical research.

At this event in Berlin, participants will meet eminent representatives from big pharma companies such as Pfizer, Sanofi, Bayer, Janssen, Novartis as well as highly qualified experts from academia and research institutes. They are enthusiastic about sharing their knowledge, experience and practices and provide further advices and fresh ideas to their business peers.

Aberdeen scientists have demonstrated for the first time a clear link between sunlight, vitamin D and an impact on regulatory cells in the immune system in findings that might provide new insights into diseases such as multiple sclerosis.

Scientists at The University of Nottingham believe they’ve found a way of fighting obesity - with a pioneering technique which uses thermal imaging. This heat-seeking technology is being used to trace our reserves of brown fat - the body’s ‘good fat’ - which plays a key role in how quickly our body can burn calories as energy.

An international team of researchers, led by the Universitat Autònoma de Barcelona and the University of York, has provided the first molecular evidence that Neanderthals not only ate a range of cooked plant foods, but also understood its nutritional and medicinal qualities.

From medical implants to new drug treatments, nanotechnology is the big new hope for the future of health and human wellbeing but how to manufacture and scale up the production of nanoparticles and nanocomposites from an engineering point of view is a major challenge.